Lornoxicam (Chlortenoxicam) is an orally active oxycontin nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, antipyretic and anticancer activities. Lornoxicam exhibits good inhibitory effects on both COX-1 and COX-2 ( COX-1 : IC 50 =0.005 μM; COX-2 : IC 50 =0.008 μM) and inhibits the production of NO by iNOS ( IC 50 =65 μM) and the proinflammatory cytokine IL-6 ( IC 50 =54 μM). Lornoxicam also inhibits tumor cell proliferation and migration and induces tumor cell apoptosis . Lornoxicam can be used in the study of inflammatory pain, colorectal cancer and breast cancer.